Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis (Q34991323)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis (English)

1 reference

Europe PubMed Central

5 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zhao-Ru Dong

1

1 reference

Europe PubMed Central

5 August 2017

Peng-Fei Zhang

2

1 reference

Europe PubMed Central

5 August 2017

Cheng-Hao Wang

3

1 reference

Europe PubMed Central

5 August 2017

Chi Zhang

4

1 reference

Europe PubMed Central

5 August 2017

Jia-Bin Cai

5

1 reference

Europe PubMed Central

5 August 2017

Guo-Ming Shi

6

1 reference

Europe PubMed Central

5 August 2017

Ai-Wu Ke

7

1 reference

Europe PubMed Central

5 August 2017

Hui-Chuan Sun

8

1 reference

Europe PubMed Central

5 August 2017

Shuang-Jian Qiu

9

1 reference

Europe PubMed Central

5 August 2017

Jian Zhou

10

1 reference

Europe PubMed Central

5 August 2017

Jia Fan

11

1 reference

Europe PubMed Central

5 August 2017

publication date

15 December 2014

1 reference

Europe PubMed Central

5 August 2017

American Journal of Cancer Research

1 reference

Europe PubMed Central

5 August 2017

5

1 reference

Europe PubMed Central

5 August 2017

1

1 reference

Europe PubMed Central

5 August 2017

450-457

1 reference

Europe PubMed Central

5 August 2017

Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Management of hepatocellular carcinoma: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

8 July 2018

Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

26 October 2018

Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

26 October 2018

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

26 October 2018

Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

26 October 2018

Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4300716

26 October 2018

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Volume reduction surgery for advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transarterial chemoembolization for intrahepatic multiple recurrent HCC after liver resection or transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT

1 reference

https://pubmed.ncbi.nlm.nih.gov/25628953

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34991323&oldid=1960300479"